ASTRAZENECA PLC DL-,25/ GB0009895292 /
2024-03-28 8:37:17 AM | Chg. +3.20 | Volume | Bid12:04:35 PM | Ask12:04:35 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
125.50EUR | +2.62% | 0 Turnover: 0.00 |
125.95Bid Size: 20 | 126.05Ask Size: 216 | 193.74 bill.EUR | - | - |
GlobeNewswire
11:00 AM
Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of Directors
GlobeNewswire
1:00 AM
HUTCHMED Announces Savolitinib sNDA Accepted in China for Treatment-Naïve or Previously Treated Pati...
GlobeNewswire
03-20
FundaMental Pharma Appoints Industry Veteran Dr. Lorenz Mayr as Non-Executive Director
GlobeNewswire
03-19
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Fusion Phar...
GlobeNewswire
02-26
FibroGen Regains All Rights to Roxadustat from AstraZeneca in the United States and Other AstraZenec...
GlobeNewswire
02-05
Yiviva Announces Memorandum of Understanding with AstraZeneca to Develop Platforms, Technologies, an...
GlobeNewswire
02-02
BridgeBio Pharma Shares Positive Results of Single-Arm Phase 3 Study of Acoramidis in Japanese Patie...